Globant, also known as Globant S.A., a publicly owned company headquartered in the US, was founded in 2003 and operates with approximately 24,050 employees. The company reported $2.4B in revenue as of 2024 and functions as a tier 1 media tech buyer. Globant specializes in providing IT services and consulting.
On February 19, 2026, PharmaMar and Globant deployed a new multi-agent artificial intelligence framework, developed using Globant Enterprise AI, to accelerate cancer drug discovery. This system delivers over 90% accuracy in complex data retrieval and generates insights up to 15 times faster, enabling researchers to identify high-potential drug candidates more efficiently. This follows the announcement on February 18, 2026, of a new collaboration between PharmaMar and Globant designed to speed up cancer drug discovery through artificial intelligence.
Globant offers 4 products in the media tech industry. Globant's product portfolio comprises of live production, broadcast professional services and sports tech.
Subscribe for full access to Globant's products in full detail
Globant's revenues were $2.4B in 2024. Caretta Research has split Globant's revenue into 4 different product categories.
Subscribe for full access to Globant's revenue in full detail
Globant's customers primarily consist of hospitals and Health Care and entertainment Providers companies. Examples of Globant's customers include The Walt Disney Company, NBCUniversal and Johnson & Johnson. Globant has commercial and technical partners like Nvidia, Ticketmaster and Amazon Web Services (AWS). Examples of Globant's suppliers include Aiva Technologies and Google.
Subscribe for full access to Globant's products in full detail 
